| Product NDC: | 0069-4395 |
| Proprietary Name: | Ciprofloxacin |
| Non Proprietary Name: | Ciprofloxacin |
| Active Ingredient(s): | 2 mg/mL & nbsp; Ciprofloxacin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-4395 |
| Labeler Name: | Pfizer Labs, Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078024 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090911 |
| Package NDC: | 0069-4395-19 |
| Package Description: | 100 mL in 1 BAG (0069-4395-19) |
| NDC Code | 0069-4395-19 |
| Proprietary Name | Ciprofloxacin |
| Package Description | 100 mL in 1 BAG (0069-4395-19) |
| Product NDC | 0069-4395 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ciprofloxacin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090911 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Labs, Division of Pfizer Inc |
| Substance Name | CIPROFLOXACIN |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |